dexamethasone implant dex i Search Results


dexamethasone implant dex i  (Allergan)
86
Allergan dexamethasone implant dex i
Macular OCT 3 months after <t>a</t> <t>DEX-I</t> injection ( a ), 1 month after the initial vitrectomy ( b ), and 1 month after removal of a DEX-I injection ( c ), showing complete disappearance of the ME. OCT, optical coherence tomography; DEX-I, <t>dexamethasone</t> implant.
Dexamethasone Implant Dex I, supplied by Allergan, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dexamethasone+implant+dex+i/dexamethasone/pmc12851610-8-3-9
Average 86 stars, based on 1 article reviews
dexamethasone implant dex i - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

Image Search Results


Macular OCT 3 months after a DEX-I injection ( a ), 1 month after the initial vitrectomy ( b ), and 1 month after removal of a DEX-I injection ( c ), showing complete disappearance of the ME. OCT, optical coherence tomography; DEX-I, dexamethasone implant.

Journal: Case Reports in Ophthalmology

Article Title: Anterior Chamber Migration of Dexamethasone Implant in a Patient Implanted with Carlevale Sutureless Scleral Fixation Intraocular Lens: A Case Report

doi: 10.1159/000550135

Figure Lengend Snippet: Macular OCT 3 months after a DEX-I injection ( a ), 1 month after the initial vitrectomy ( b ), and 1 month after removal of a DEX-I injection ( c ), showing complete disappearance of the ME. OCT, optical coherence tomography; DEX-I, dexamethasone implant.

Article Snippet: Intravitreal injection of dexamethasone implant (DEX-I) (Ozurdex ® , Allergan, Irvine, CA, USA) has demonstrated efficacy in various clinical scenarios, including macular edema (ME) resulting from retinal vein occlusion, noninfectious uveitis affecting the posterior segment, diabetic ME, or Irvine-Gass syndrome [ – ].

Techniques: Injection, Tomography

Anterior segment photography showing DEX-I in the anterior chamber, and corneal edema. DEX-I, dexamethasone implant.

Journal: Case Reports in Ophthalmology

Article Title: Anterior Chamber Migration of Dexamethasone Implant in a Patient Implanted with Carlevale Sutureless Scleral Fixation Intraocular Lens: A Case Report

doi: 10.1159/000550135

Figure Lengend Snippet: Anterior segment photography showing DEX-I in the anterior chamber, and corneal edema. DEX-I, dexamethasone implant.

Article Snippet: Intravitreal injection of dexamethasone implant (DEX-I) (Ozurdex ® , Allergan, Irvine, CA, USA) has demonstrated efficacy in various clinical scenarios, including macular edema (ME) resulting from retinal vein occlusion, noninfectious uveitis affecting the posterior segment, diabetic ME, or Irvine-Gass syndrome [ – ].

Techniques: